CellCentric vs Epicrispr Biotechnologies
CellCentric vs Epicrispr Biotechnologies, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CellCentric is on 60/100 and Epicrispr Biotechnologies on 62/100.
Where each one leads
CellCentric
- funding raised: $375M against $90.0M
- LinkedIn following: 28,695 against 7,025
Epicrispr Biotechnologies
- agent readiness: 39/100 against 32/100
- domain rating: 40/100 against 35/100
At a glance
| Measure | CellCentric | Epicrispr Biotechnologies |
|---|---|---|
| What it is | A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma. | Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Biotech | Biotechnology, Therapeutics, Rare Diseases, Epigenetics |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2003 | 2020 |
| Headquarters | Cambridge, United Kingdom | South San Francisco, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | CellCentric | Epicrispr Biotechnologies |
|---|---|---|
| Employees | 53 | 51 |
| Total funding | $375M | $90.0M |
| Latest round | Series D | Series C |
| LinkedIn followers | 28,695 | 7,025 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CellCentric | Epicrispr Biotechnologies |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 62/100 |
| Traction | 57/100 | 57/100 |
| Team | 60/100 | 40/100 |
| Search visibility | 44/100 | 20/100 |
| Quality | 68/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 35/100 | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CellCentric | Epicrispr Biotechnologies |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery, Tailwind CSS, Bootstrap |
| Analytics | Google Analytics 4 | Google Analytics 4 |
CellCentric vs Epicrispr Biotechnologies: common questions
Which is better, CellCentric or Epicrispr Biotechnologies?
On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 60/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.
How do CellCentric and Epicrispr Biotechnologies compare on the numbers?
CellCentric leads on funding raised ($375M against $90.0M), LinkedIn following (28,695 against 7,025). Epicrispr Biotechnologies leads on agent readiness (39/100 against 32/100), domain rating (40/100 against 35/100).
Read the full CellCentric review and pricing or the Epicrispr Biotechnologies review and pricing. You can also browse other CellCentric alternatives we track.